The National Center for Advancing Translational Sciences (NCATS) has developed Inxight: Drugs
A comprehensive portal for drug development information. NCATS Inxight: Drugs contains information on ingredients in medicinal products, including:
| US APPROVED DRUGS: 2,553 |
| MARKETED DRUGS: 6,161 |
| INVESTIGATIONAL DRUGS: 6,791 |
| ALL SUBSTANCES: 102,012 |
2018 Overview of FDA Approved Drugs:
– Highest ever number of innovative drugs approved in a year.
– FDA approves first-ever RNAi therapeutic. (patisiran )
– The first pharmaceutical derived from marijuana approved. (cannabidiol)
– First single-dose medicine to prevent the relapse of P. vivax malaria. (tafenoquine)
